Centrally bradykinin B2-receptor-induced hypertensive and positive chronotropic effects are mediated via activation of the sympathetic nervous system

Journal of Hypertension

Volumn 17, Issue 9, 1999, Pages 1265-1271

  Qadri, Fatimunnisa ^a   Bäurle, Leif ^a   Häuser, Walter ^a   Rascher, Wolfgang ^b   Dominiak, Peter ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Bradykinin and adrenoceptors; Brain; Catecholamines; Sympathetic nervous system; Vasopressin; Wistar Kyoto rats

Indexed keywords

ADRENALIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ARGININE; ARGIPRESSIN[1 (3,3 CYCLOPENTAMETHYLENE 3 MERCAPTOPROPIONIC ACID) 2 (O METHYLTYROSINE)]; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; ICATIBANT; NORADRENALIN; PEPTIDE HORMONE ANTAGONIST; PRAZOSIN; VASOPRESSIN; ALPHA 1 ADRENERGIC RECEPTOR; ARGIPRESSIN; BETA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRADYKININ; BRADYKININ RECEPTOR; CATECHOLAMINE; DRUG DERIVATIVE; VASOPRESSIN RECEPTOR;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARTICLE; CHRONOTROPISM; CONTROLLED STUDY; DOPAMINE BLOOD LEVEL; FEMORAL ARTERY; FEMORAL VEIN; HEART RATE; HYPERTENSION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; VASOPRESSIN BLOOD LEVEL; ANIMAL; BLOOD; BLOOD PRESSURE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PHYSIOLOGY; STIMULATION; WISTAR KYOTO RAT;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ARGININE VASOPRESSIN; BLOOD PRESSURE; BRADYKININ; CATECHOLAMINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; INJECTIONS, INTRAVENTRICULAR; MALE; RATS; RATS, INBRED WKY; RECEPTOR, BRADYKININ B2; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, BRADYKININ; RECEPTORS, VASOPRESSIN; STIMULATION, CHEMICAL; SYMPATHETIC NERVOUS SYSTEM;

EID: 0032588551     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917090-00005     Document Type: Article

References (35)

1. 1 Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 1992; 44:1-80.
2. 2 Walker K, Perkins M, Dray A. Kinins and kinin receptors in the nervous system. Neurochem Int 1995; 26; 1-26.
3. 3 Lindsay CN, Nakai CR, Martins DTO. Central nervous system kinin receptors and the hypertensive response mediated by bradykinin. Br J Pharmacol 1989; 97:763-768.
4. 4 Madeddu P, Glorioso N, Soro A, Tonolo GC, Manunta P, Troffa C, et al. Brain kinins are responsible for the pressor effect of intracerebroventricular captopril in spontaneously hypertensive rats. Hypertension 1990; 15:407-412.
5. 125l)-bradykinin binding sites in guinea pig brain. Brain Res 1992; 577:73-79.
6. 8]-bradykinin receptor binding sites in the rat spinal cord: effects of neonatal capsaicin, noradrenergic deafferentation, dorsal rhizotomy and peripheral axotomy. Neuroscience 1995; 68:867-881.
7. 2 receptors in the guinea pig using a radioiodinated Hoe 140 analogue. Eur J Pharmacol 1996; 306:237-247.
8. 2 receptors in sheep brain and spinal cord visualized by in vitro autoradiography. J Comp Neurol 1997; 381:203-218.
9. 2 receptors in rat brain. J Hypertens 1997; 15 (suppl 4):S186.
10. 10 Drouhault R, Abrous N, David J-P, Dufy B. Bradykinin parallels thyrotropin-releasing hormone actions on prolactin release from rat anterior pituitary cells. Neuroendocrinology 1987; 46:360-364.
11. 11 Madeddu P, Anania V, Alagna S, Troffa C, Parpaglia PP, Tonolo G, et al. Role of brain kallikrein-kinin system in regulation of adrenocorticotropin release. Am J Physiol 1992; 262:E312-E318.
12. 12 Malendowicz LK, Macchi C, Nussdorfer GG, Markowska A. Effects of the prolonged administration of bradykinin on the rat pituitary-adrenocortical axis. Histol Histopathol 1996; 11:641-645.
13. 13 Okajima T, Hertting G. Bradykinin-induced ACTH release from rat pituitary tissue in vitro. Neuroendocrinology 1986; 43:336-339.
14. 14 Dendorfer A, Dominiak P. Characterization of bradykinin receptors mediating catecholamine release in PC12 cells. Naunyn-Schmiedeberg's Arch Pharmacol 1995; 351:274-281.
15. 15 Erikson BM, Persson BA. Determination of catecholamines in rat heart tissue and plasma samples by liquid chromatography with electrochemical detection. J Chromatogr 1982, 228:143-154.
16. 16 Dehner R, Kees F, Grobecker H. Vereinfachte Probenvorbereitung und sensibler Nachweis von Plasma-und Gewebe-Katecholaminen mit HPLC-ECD. Würzburger Chromatographie-Geshpräche, 1989; 4:65-68.
17. 17 Rascher W, Weidman E, Gross F. Vasopressin in the plasma of stroke-prone spontaneously hypertensive rats. Clin Sci 1981; 61:295-298.
18. 18 Bunag RD, Takahasi H. Exaggerated sympathetic responses to bradykinin in spontaneously hypertensive rats. Hypertension 1981; 3:433-440.
19. 19 Takahashi H, Bunag RD. Centrally induced cardiovascular and sympathetic nerve responses to bradykinin in rats. J Pharmacol Exp Ther 1981; 216:192-197.
20. 20 Lopes P, Couture R. Cardiovascular responses elicited by intrathecal kinins in the conscious rat. Eur J Pharmacol 1992; 210:137-147.
21. 21 Dominiak P, Simon M, Blöchl A, Brenner P. Changes in sympathetic outflow of pithed spontaneously hypertensive rats after bradykinin and DesArgbradykinin infusions: influence of converting-enzyme inhibition. J Cardiovasc Pharmacol 1992; 20:S35-S38.
22. 22 Badoer E, Würth H, Türck D, Qadri F, Itoi K, Dominiak P, et al. The K'-induced increase in noradrenaline and dopamine release are accompanied by reductions in the release of their intraneuronal metabolites from the rat anterior hypothalamus. An in vivo brain microdiaylsis study. Nauyn-Schmiedeberg's Arch Pharmacol 1989; 339:54-59.
23. 23 Qadri F, Badoer E, Stadler T, Unger T. Angiotensin II-induced noradrenaline release from anterior hypothalamus in conscious rats: a brain microdialysis study. Brain Res, 1991; 563:137-141.
24. 24 Qadri F, Culman J, Veltmar A, Maas K, Rascher W, Unger T. Angiotensin II-induced vasopressin release is mediated through alpha 1-adrenoceptors and angiotensin II AT1 receptors in the supraoptic nucleus. J Pharmacol Exp Ther 1993; 267:567-574.
25. 25 Stadler T, Veltmar A, Qadri F, Unger T. Angiotensin evokes noradrenaline release from the paraventricular nucleus in conscious rats. Brain Res 1992; 569:117-122.
26. 26 Loro JF, Zhang J, Pfaffendorf M, Van Zwieten PA. Positive chronotropic activity of bradykinin in the pithed normotensive rat. Fund Clin Pharmacol 1998; 12:77-81.
27. 27 McKinley MJ, McAllen MR, Mendelsohn FAO, Allen AM, Chai SY, Oldfield BJ. Circumventricular organs: neuroendocrine interfaces between the brain and the hemal milieu. Front Neuroendocrinol 1990; 11:91-127.
28. 28 Dampney RAL. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 1994; 74:323-363.
29. 29 Spyer KM. Central nervous mechanisms contributing to cardiovascular control. J Physiol 1994; 474:1-19.
30. 30 Diz DI, Jacobowitz DM. Cardiovascular effects of discrete intrahypothalamic and preoptic injections of bradykinin. Brain Res Bull 1984; 409:409-417.
31. 31 Brooks DP, Share L, Crofon JT, Nasjletti A. Interrelationship between central bradykinin and vasopressin in conscious rats. Brain Res 1986; 371:42-48.
32. 32 Hoffman WE, Schmid PG. Separation of pressor and antidiuretic effects of intraventricular bradykinin. Neuropharmacology 1978; 17:999-1002.
33. 33 Harris MC. Release of antidiuretic substance by bradykinin in the rat. J Physiol 1971; 219:403-419.
34. 34 Qadri F, Wolf A, Waldmann T, Rascher W, Unger T. Sensitivity of hypothalamic paraventricular nucleus to C-and N-terminal angiotensin fragments: vasopressin release and drinking. J Neuroendocrinol 1998; 10:275-281.
35. 35 Qadri F, Waldmann T, Wolf A, Höhle S, Rascher W, Unger T. Differential contribution of angiotensinergic and cholinergic receptors in the hypothalamic paraventricular nucleus to osmotically induced AVP release. J Pharmacol Exp Ther 1998; 285:1012-1018.